Bringing novel gene therapies from the drawing board to patients requires careful consideration of each step of the pipeline. A key component is developing manufacturing processes that can pass the requirements of regulatory agencies. Additionally, biotechs must consider the logistics of bringing their products to clinical testing sites. A new Catalent webinar covers these issues in-depth .
According to Catalent, “In this webinar, hear from Catalent panelists Denise Krohn, VP of Quality (Harmans/BWI), and Ann McMahon, Program Director Clinical Supply Services & Drug Product Technologies Integrations, as they discuss navigating the path.”
To learn more, click here.
(Source: Cell and Gene, May 25th, 2022)